查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1862165

药品临床试验供给与物流：全球市占率与排名、总收入及需求预测（2025-2031 年）

Clinical Trial Supply and Logistic for Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 109 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球医药临床试验用品和物流市场预计在 2024 年达到 23.6 亿美元，预计到 2031 年将达到 40.66 亿美元，2025 年至 2031 年的复合年增长率为 8.2%。

药物临床试验供应与物流是一个专业的服务体系，为製药公司、受託研究机构(CRO) 和研究机构提供贯穿整个临床试验生命週期的药物和物料的全面供应、储存、配送和温控运输服务。这些服务包括生产后的临床包装、贴标、试剂盒组装、批次追溯、全球供应链设计、清关、符合 GMP/GDP 标准的仓储以及精准数位化供应链管理、智慧温控解决方案和符合全球标准的网络，我们提供端到端、全程可追溯的服务，加速药物研发到商业化的进程。

受药物研发週期缩短和全球临床试验网络不断扩展的推动，医药临床试验供应和物流行业正经历前所未有的成长。精准医疗、细胞和基因疗法、RNA药物以及罕见疾病治疗的快速发展，对供应链的灵活性、可追溯性和合规性提出了更高的要求。对数位化供应链解决方案、自动化仓库和智慧运输设备的投资，不仅提高了製药公司的营运效率，也增强了其进入全球市场的管道。政府对医药创新的激励措施和加速核准流程，正在促进业内跨境合作的标准化。

主要挑战包括监管合规成本、国际物流的复杂性、资源分配压力。严格的全球GMP/GDP标准和低温运输运输需求需要持续投资于技术和专业人才。跨境临床试验进一步加剧了供应链协调的复杂性，而地缘政治的不确定性、公共卫生危机以及物流能力的波动则增加了营运风险。此外，对创新治疗方法的小批量、大容量和快速响应供应模式的需求不断增长，推高了成本，并提高了对供应链灵活性的需求。

随着全球创新药物研发管线的不断扩展，临床试验的供应和物流需求正从基本的仓储和运输服务转向全面的端到端解决方案。製药公司、合约研究机构 (CRO) 和生技公司越来越重视合规透明度和即时供应链视觉性，以缩短研发週期并优化资源利用。精准医疗的进步正在推动对生物样本物流、伴随诊断和直接面向患者 (DTP) 的需求，促使业界朝着更数据驱动和个性化的服务方向发展。预计这一领域将与数位化临床试验平台和分散式试验模式深度融合，并成为药物研发的策略资产。

上游供应链由低温运输技术、专用包装材料、运输容器和数位化管理系统组成。领先的低温运输解决方案和智慧包装供应商不断创新，以确保药物在储存和运输过程中的稳定性。高性能隔热材料、智慧温度感测器和一次性包装已成为业界标准。同时，先进的供应链管理平台、自动化仓储系统和追踪技术的整合，增强了全生命週期供应链能力，并保障了全球临床试验专案的安全高效运作。

本报告旨在按地区/国家、类型和应用对全球医药临床试验用品和物流市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告以收益为准，以2024年为基准年，对医药临床试验供应和物流市场规模、估计值和预测进行了阐述，并涵盖了2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定业务/成长策略、评估市场竞争、分析自身在当前市场中的地位，并就医药临床试验供应和物流做出明智的商业决策。

市场区隔

公司

  • Thermo Fisher Scientific
  • Catalent Pharma Solutions
  • Almac Group
  • Parexel International
  • UDG Healthcare
  • PCI Services
  • Marken
  • Klifo A/S.
  • Walden Group
  • Bilcare Limited
  • Biocair

按类型分類的细分市场

  • 物流与配送
  • 生产/包装
  • 供应链管理
  • 其他的

应用领域

  • 第一阶段
  • 第二阶段
  • 第三阶段

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Clinical Trial Supply and Logistic for Pharmaceutical was estimated to be worth US$ 2360 million in 2024 and is forecast to a readjusted size of US$ 4066 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

Clinical Trial Supply and Logistic for Pharmaceutical refers to a specialized service system providing comprehensive drug and material supply, storage, distribution, and temperature-controlled transportation throughout the entire clinical trial lifecycle for pharmaceutical companies, contract research organizations (CROs), and research institutions. This service encompasses post-manufacturing clinical packaging, labeling, kit assembly, batch traceability, global supply chain design, customs clearance, GMP/GDP-compliant warehousing, and precise distribution. With increasing trial complexity and the growth of multi-center, cross-regional clinical studies, clinical trial supply and logistics have become essential in mitigating R&D risks, improving trial efficiency, and safeguarding patient safety. Through digitalized supply chain management, intelligent temperature-control solutions, and globally compliant networks, the sector offers end-to-end, fully traceable services that accelerate the path from drug development to commercialization.

The pharmaceutical clinical trial supply and logistics sector is experiencing unprecedented growth driven by shorter drug development cycles and the expansion of global clinical trial networks. The rapid advancement of precision medicine, cell and gene therapies, RNA-based drugs, and rare disease treatments is raising the bar for supply chain flexibility, traceability, and regulatory compliance. Investment in digitalized supply chain solutions, automated warehousing, and intelligent transport equipment not only enhances operational efficiency for pharmaceutical companies but also strengthens global market access. Government incentives for drug innovation and accelerated approval pathways are fostering standardized, cross-border collaboration within the industry.

Key challenges include regulatory compliance costs, the complexity of international logistics, and resource allocation pressures. Strict GMP/GDP standards and cold-chain transportation requirements worldwide necessitate continuous investments in technology and skilled personnel. Cross-border trials further complicate supply chain coordination, while geopolitical uncertainties, public health crises, and logistics capacity fluctuations heighten operational risks. Additionally, increasing demand for small-batch, multi-lot, rapid-response supply models for innovative therapies has driven up costs and supply chain agility requirements.

As the global pipeline of innovative drugs expands, the demand for clinical trial supply and logistics is shifting from basic storage and transport services to comprehensive end-to-end solutions. Pharmaceutical companies, CROs, and biotech firms increasingly prioritize compliance transparency and real-time supply chain visibility to shorten development timelines and optimize resource use. Precision medicine is driving demand for biological sample logistics, companion diagnostics, and direct-to-patient (DTP) delivery, pushing the industry toward more data-driven, personalized, and customized services. The sector is set to deeply integrate with digital clinical trial platforms and decentralized trial models, becoming a strategic asset in drug R&D.

The upstream supply chain comprises cold-chain technology, specialized packaging materials, transport containers, and digital management systems. Leading suppliers of cold-chain solutions and intelligent packaging continuously innovate to ensure drug stability during storage and transportation. High-performance insulation materials, smart temperature sensors, and single-use packaging have become standard in the industry. At the same time, the integration of advanced supply chain management platforms, automated warehousing systems, and tracking technologies strengthens lifecycle supply chain capabilities, ensuring secure and efficient operations for global clinical trial programs.

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Supply and Logistic for Pharmaceutical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Supply and Logistic for Pharmaceutical by region & country, by Type, and by Application.

The Clinical Trial Supply and Logistic for Pharmaceutical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Supply and Logistic for Pharmaceutical.

Market Segmentation

By Company

  • Thermo Fisher Scientific
  • Catalent Pharma Solutions
  • Almac Group
  • Parexel International
  • UDG Healthcare
  • PCI Services
  • Marken
  • Klifo A/S.
  • Walden Group
  • Bilcare Limited
  • Biocair

Segment by Type

  • Logistics & Distribution
  • Manufacturing and Packaging
  • Supply Chain Management
  • Other

Segment by Application

  • Phase I
  • Phase II
  • Phase III

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Clinical Trial Supply and Logistic for Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Clinical Trial Supply and Logistic for Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Clinical Trial Supply and Logistic for Pharmaceutical in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Clinical Trial Supply and Logistic for Pharmaceutical Product Introduction
  • 1.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Market Size Forecast (2020-2031)
  • 1.3 Clinical Trial Supply and Logistic for Pharmaceutical Market Trends & Drivers
    • 1.3.1 Clinical Trial Supply and Logistic for Pharmaceutical Industry Trends
    • 1.3.2 Clinical Trial Supply and Logistic for Pharmaceutical Market Drivers & Opportunity
    • 1.3.3 Clinical Trial Supply and Logistic for Pharmaceutical Market Challenges
    • 1.3.4 Clinical Trial Supply and Logistic for Pharmaceutical Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Players Revenue Ranking (2024)
  • 2.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Revenue by Company (2020-2025)
  • 2.3 Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Clinical Trial Supply and Logistic for Pharmaceutical
  • 2.6 Clinical Trial Supply and Logistic for Pharmaceutical Market Competitive Analysis
    • 2.6.1 Clinical Trial Supply and Logistic for Pharmaceutical Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Supply and Logistic for Pharmaceutical Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supply and Logistic for Pharmaceutical as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Logistics & Distribution
    • 3.1.2 Manufacturing and Packaging
    • 3.1.3 Supply Chain Management
    • 3.1.4 Other
  • 3.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type
    • 3.2.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Type (2020-2031)
    • 3.2.3 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Phase I
    • 4.1.2 Phase II
    • 4.1.3 Phase III
  • 4.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application
    • 4.2.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Application (2020-2031)
    • 4.2.3 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region
    • 5.1.1 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2020-2025)
    • 5.1.3 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2026-2031)
    • 5.1.4 Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.2.2 North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.3.2 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.5.2 South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.3.2 United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.4.2 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.5.2 China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.6.2 Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.7.2 South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020-2031
    • 6.9.2 India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher Scientific
    • 7.1.1 Thermo Fisher Scientific Profile
    • 7.1.2 Thermo Fisher Scientific Main Business
    • 7.1.3 Thermo Fisher Scientific Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.1.4 Thermo Fisher Scientific Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Thermo Fisher Scientific Recent Developments
  • 7.2 Catalent Pharma Solutions
    • 7.2.1 Catalent Pharma Solutions Profile
    • 7.2.2 Catalent Pharma Solutions Main Business
    • 7.2.3 Catalent Pharma Solutions Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.2.4 Catalent Pharma Solutions Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Catalent Pharma Solutions Recent Developments
  • 7.3 Almac Group
    • 7.3.1 Almac Group Profile
    • 7.3.2 Almac Group Main Business
    • 7.3.3 Almac Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.3.4 Almac Group Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Almac Group Recent Developments
  • 7.4 Parexel International
    • 7.4.1 Parexel International Profile
    • 7.4.2 Parexel International Main Business
    • 7.4.3 Parexel International Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.4.4 Parexel International Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Parexel International Recent Developments
  • 7.5 UDG Healthcare
    • 7.5.1 UDG Healthcare Profile
    • 7.5.2 UDG Healthcare Main Business
    • 7.5.3 UDG Healthcare Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.5.4 UDG Healthcare Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.5.5 UDG Healthcare Recent Developments
  • 7.6 PCI Services
    • 7.6.1 PCI Services Profile
    • 7.6.2 PCI Services Main Business
    • 7.6.3 PCI Services Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.6.4 PCI Services Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.6.5 PCI Services Recent Developments
  • 7.7 Marken
    • 7.7.1 Marken Profile
    • 7.7.2 Marken Main Business
    • 7.7.3 Marken Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.7.4 Marken Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Marken Recent Developments
  • 7.8 Klifo A/S.
    • 7.8.1 Klifo A/S. Profile
    • 7.8.2 Klifo A/S. Main Business
    • 7.8.3 Klifo A/S. Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.8.4 Klifo A/S. Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Klifo A/S. Recent Developments
  • 7.9 Walden Group
    • 7.9.1 Walden Group Profile
    • 7.9.2 Walden Group Main Business
    • 7.9.3 Walden Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.9.4 Walden Group Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Walden Group Recent Developments
  • 7.10 Bilcare Limited
    • 7.10.1 Bilcare Limited Profile
    • 7.10.2 Bilcare Limited Main Business
    • 7.10.3 Bilcare Limited Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.10.4 Bilcare Limited Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Bilcare Limited Recent Developments
  • 7.11 Biocair
    • 7.11.1 Biocair Profile
    • 7.11.2 Biocair Main Business
    • 7.11.3 Biocair Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
    • 7.11.4 Biocair Clinical Trial Supply and Logistic for Pharmaceutical Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Biocair Recent Developments

8 Industry Chain Analysis

  • 8.1 Clinical Trial Supply and Logistic for Pharmaceutical Industrial Chain
  • 8.2 Clinical Trial Supply and Logistic for Pharmaceutical Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Clinical Trial Supply and Logistic for Pharmaceutical Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Clinical Trial Supply and Logistic for Pharmaceutical Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Clinical Trial Supply and Logistic for Pharmaceutical Market Trends
  • Table 2. Clinical Trial Supply and Logistic for Pharmaceutical Market Drivers & Opportunity
  • Table 3. Clinical Trial Supply and Logistic for Pharmaceutical Market Challenges
  • Table 4. Clinical Trial Supply and Logistic for Pharmaceutical Market Restraints
  • Table 5. Global Clinical Trial Supply and Logistic for Pharmaceutical Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Clinical Trial Supply and Logistic for Pharmaceutical Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Clinical Trial Supply and Logistic for Pharmaceutical Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Clinical Trial Supply and Logistic for Pharmaceutical
  • Table 10. Global Clinical Trial Supply and Logistic for Pharmaceutical Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supply and Logistic for Pharmaceutical as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Thermo Fisher Scientific Basic Information List
  • Table 32. Thermo Fisher Scientific Description and Business Overview
  • Table 33. Thermo Fisher Scientific Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Thermo Fisher Scientific (2020-2025)
  • Table 35. Thermo Fisher Scientific Recent Developments
  • Table 36. Catalent Pharma Solutions Basic Information List
  • Table 37. Catalent Pharma Solutions Description and Business Overview
  • Table 38. Catalent Pharma Solutions Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Catalent Pharma Solutions (2020-2025)
  • Table 40. Catalent Pharma Solutions Recent Developments
  • Table 41. Almac Group Basic Information List
  • Table 42. Almac Group Description and Business Overview
  • Table 43. Almac Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Almac Group (2020-2025)
  • Table 45. Almac Group Recent Developments
  • Table 46. Parexel International Basic Information List
  • Table 47. Parexel International Description and Business Overview
  • Table 48. Parexel International Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Parexel International (2020-2025)
  • Table 50. Parexel International Recent Developments
  • Table 51. UDG Healthcare Basic Information List
  • Table 52. UDG Healthcare Description and Business Overview
  • Table 53. UDG Healthcare Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of UDG Healthcare (2020-2025)
  • Table 55. UDG Healthcare Recent Developments
  • Table 56. PCI Services Basic Information List
  • Table 57. PCI Services Description and Business Overview
  • Table 58. PCI Services Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of PCI Services (2020-2025)
  • Table 60. PCI Services Recent Developments
  • Table 61. Marken Basic Information List
  • Table 62. Marken Description and Business Overview
  • Table 63. Marken Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Marken (2020-2025)
  • Table 65. Marken Recent Developments
  • Table 66. Klifo A/S. Basic Information List
  • Table 67. Klifo A/S. Description and Business Overview
  • Table 68. Klifo A/S. Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Klifo A/S. (2020-2025)
  • Table 70. Klifo A/S. Recent Developments
  • Table 71. Walden Group Basic Information List
  • Table 72. Walden Group Description and Business Overview
  • Table 73. Walden Group Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Walden Group (2020-2025)
  • Table 75. Walden Group Recent Developments
  • Table 76. Bilcare Limited Basic Information List
  • Table 77. Bilcare Limited Description and Business Overview
  • Table 78. Bilcare Limited Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Bilcare Limited (2020-2025)
  • Table 80. Bilcare Limited Recent Developments
  • Table 81. Biocair Basic Information List
  • Table 82. Biocair Description and Business Overview
  • Table 83. Biocair Clinical Trial Supply and Logistic for Pharmaceutical Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Clinical Trial Supply and Logistic for Pharmaceutical Business of Biocair (2020-2025)
  • Table 85. Biocair Recent Developments
  • Table 86. Key Raw Materials Lists
  • Table 87. Raw Materials Key Suppliers Lists
  • Table 88. Clinical Trial Supply and Logistic for Pharmaceutical Downstream Customers
  • Table 89. Clinical Trial Supply and Logistic for Pharmaceutical Distributors List
  • Table 90. Research Programs/Design for This Report
  • Table 91. Key Data Information from Secondary Sources
  • Table 92. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Clinical Trial Supply and Logistic for Pharmaceutical Product Picture
  • Figure 2. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Clinical Trial Supply and Logistic for Pharmaceutical Report Years Considered
  • Figure 5. Global Clinical Trial Supply and Logistic for Pharmaceutical Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Clinical Trial Supply and Logistic for Pharmaceutical Revenue in 2024
  • Figure 7. Clinical Trial Supply and Logistic for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Logistics & Distribution Picture
  • Figure 9. Manufacturing and Packaging Picture
  • Figure 10. Supply Chain Management Picture
  • Figure 11. Other Picture
  • Figure 12. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 13. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value Market Share by Type, 2024 & 2031
  • Figure 14. Product Picture of Phase I
  • Figure 15. Product Picture of Phase II
  • Figure 16. Product Picture of Phase III
  • Figure 17. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 18. Global Clinical Trial Supply and Logistic for Pharmaceutical Sales Value Market Share by Application, 2024 & 2031
  • Figure 19. North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value (2020-2031) & (US$ Million)
  • Figure 20. North America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • Figure 21. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 22. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • Figure 23. Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 24. Asia Pacific Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Region (%), 2024 VS 2031
  • Figure 25. South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 26. South America Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • Figure 27. Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 28. Middle East & Africa Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Key Countries/Regions Clinical Trial Supply and Logistic for Pharmaceutical Sales Value (%), (2020-2031)
  • Figure 30. United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 32. United States Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 33. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 35. Europe Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 36. China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 38. China Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 39. Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 41. Japan Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 42. South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 44. South Korea Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Southeast Asia Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 48. India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Type (%), 2024 VS 2031
  • Figure 50. India Clinical Trial Supply and Logistic for Pharmaceutical Sales Value by Application (%), 2024 VS 2031
  • Figure 51. Clinical Trial Supply and Logistic for Pharmaceutical Industrial Chain
  • Figure 52. Clinical Trial Supply and Logistic for Pharmaceutical Manufacturing Cost Structure
  • Figure 53. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 54. Bottom-up and Top-down Approaches for This Report
  • Figure 55. Data Triangulation
  • Figure 56. Key Executives Interviewed